I am a business developer, mainly in the field of life sciences, involved in several international very successful deals. In the meantime, since 2012, I have been in charge of teaching "International negotiation and cultural impact on deal makings" and “Technology transfer” at the University (Doctorants) and several "Grandes Ecoles" (Ecole Centrale Lyon, INSA Lyon; CPE;). Basically "Toxicology Expert", Head of the toxicology department of Lipha (subsidiary of “Air Liquide” Group) from 1981 to 1991, I was, from 1991 to 2000 Director of the Corporate Licencing of Merck-Lipha in charge of the fields of metabolic diseases (Diabetes and complications), CNS , addiction, dermato/cosmetology, OTC.... During this period, majors deals were finalized including - Out-licensing (Glucophage* to BMS-USA / 2.5 bioUSD per year), Glucophage* is still the best seller French pharma product in the USA ever ! - In-licensing (Tacalcitol from Teijin-Japan), - Companies take over (Monot now “Merck Medication Familiale”; Theramex) - Brand names: Catalgine* In 2000, with 2 other shareholders, I was involved in the set-up of a startup, ClinicalLand, devoted to the management of Clinical Trials Investigators. From 2007, after the sale of ClinicalLand, I moved as the head of Tech Transfer at Institut Pasteur in Paris with the initiation or finalization of several agreements and partnerships (HIV, Malaria, Inflammation, Tuberculosis, pain, Flue, dengue...) with Institut Mérieux, GSK Bio, Sanofi Pasteur; Servier, Danone, Stragen ....Finally, it was a wonderful experience in term of knowledge and scientific network, in one the most prestigious research Institutes in the world By the end of 2010, I joined Lyon Science Transfert, the valorization tool of the University of Lyon (11500 researchers...) now SATT Pulsalys since end of 2013 to 2016. Currently, I work as a consultant for the French company, Eris Conseil in the fields of business development, companies take-over and international business.